It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Value investing focuses on finding undervalued assets for higher returns. Learn effective strategies to enhance your investment portfolio.
26,852 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Quantum computing could reshape industries, and early investors may gain. This guide breaks down three stocks to watc...
Brokerages report wide AI use, but agents say the payoff isn’t consistently converting to more closings. A 2026 snaps...
When a Galicia director just bought a large stake, investors ask: is this a signal of confidence or a red flag? This ...
MP Materials is at the center of America’s push to secure essential minerals. This guide breaks down whether now is t...
A six-state AI pilot for Original Medicare is delaying and denying care for certain procedures, drawing bipartisan sc...
Tesla's robotaxi just launched in Miami, marking a milestone for autonomous transport. Yet the pilot comes with a del...
A recent hotel breakfast incident involving a security guard confronted 11-year-old fans sparked a conversation about...
A growing share of retirees split time across states, exposing gaps in coverage from Medicare Advantage plans. Origin...
Tilray Brands is set to report on July 28. This article breaks down whether should tilray brands stock be on your rad...
As major indices retreat in March, traders question whether Trump losing grip market? influence is waning. Volatility...
Equity futures fell and oil surged as the initial round of U.S.-Iran talks began, setting a tense tone for markets an...